Medtronic proposes to invest up to US$50 million, over a period of five years, starting from FY22, to support capability development of talent and technology.
Medtronic also engages with the best engineering talent to foster innovation in healthcare through the two R&D centers in Hyderabad and Bengaluru.
Healthcare technology company Medtronic today launched the Medtronic Open Innovation Platform (OIP) to explore partnership opportunities towards leveraging artificial intelligence (AI) and automation to address patient needs in the Asia-Pacific.
Medtronic proposes to invest up to US$50 million, over a period of five years, starting from FY22, to support capability development of talent and technology.
As part of the OIP, Medtronic also launched the Medtronic APAC Innovation Challenge (MAIC), where business organizations in APAC will have the opportunity to showcase innovative medical technology solutions in one of the four domains – namely, ‘Life Transforming Technologies’, ‘Better Outcomes for All’, ‘Experiences that Put People First’ and ‘Insight Driven Care’. MAIC will provide an opportunity to selected participants to collaborate with Medtronic to further develop and innovate their solutions.
The OIP is aimed at bringing strategic collaboration in healthcare technologies from various innovators and stakeholders across the Asia-Pacific in the areas of medical technology and digital health.
“Building on the entrepreneurial spirit that we share with other companies including our Medtronic OIP start-ups serves as a launch pad for us to grow new ideas, empower an innovative ecosystem and translate this collaboration into actionable outcomes. Medtronic is one of the best destinations for innovation and innovators due to its large and diverse portfolio across 70 disease states. This is indeed aligned to our new brand and bold ambition to become the global healthcare technology leader, with a focus on AI, robotics, automation, IoT and digital health,” said Chris Lee, president for Asia Pacific, Medtronic.
MAIC, which is open for submissions now, is scheduled to take place alongside the Medtronic Asia Innovation Conference in the first quarter of 2022 and will be hosted at Medtronic’s regional headquarters in Singapore.
The top five winners of the MAIC may have the opportunity to partner with Medtronic to explore joint commercialisation of products and/or run commercial pilots for their proposed MedTech or digital health product solutions.
“Medtronic has always disrupted the market with innovative technologies and solutions. This time with MAIC, we are offering a platform to reach the most disruptive business organisations that can contribute to accelerating the global healthcare goals. Through the Innovation Challenge, we are inviting the best entrepreneurial minds in the country to catapult their vision for India into reality. The program also aligns with the Government of India’s vision to promote Make in India,” said Madan Krishnan, vice president and managing director, Medtronic India.
Medtronic has been promoting talent and innovation within India through a plethora of programs with the recent one done in partnership with Stasis Health Private Limited for scaling up and expanding access for their state-of-the-art Stasis Monitor, a connected care bedside multi parameter monitoring system.
Medtronic also engages with the best engineering talent to foster innovation in healthcare through the two R&D centers in Hyderabad and Bengaluru.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs,
calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
